Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2003
12/11/2003CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003CA2490051A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate
12/11/2003CA2488568A1 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003CA2488547A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003CA2488539A1 Novel proteins and nucleic acids encoding same
12/11/2003CA2488441A1 Synthetic antibody phage libraries
12/11/2003CA2488270A1 Paramyxoviral vectors encoding antibodies, and uses thereof
12/11/2003CA2487939A1 Semaphorin-like proteins and methods of using same
12/11/2003CA2487932A1 Cd16a binding proteins and use for the treatment of immune disorders
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2487895A1 Defensins: use as antiviral agents
12/11/2003CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003CA2486423A1 Antibodies and their use for the modulation of taste sensation
12/11/2003CA2480326A1 Knockout mice and their use
12/11/2003CA2478925A1 Non-affinity purification of proteins
12/10/2003EP1369483A1 Allergen from mugwort pollen
12/10/2003EP1369479A1 Novel cell adhesion molecule specific to activated leukocyte
12/10/2003EP1369431A1 Anti-hla-dr antibody
12/10/2003EP1369430A2 Two human G-Protein coupled receptors: EBV-induced GPCR 2(EBI-2) and EBG-1-like GPCR
12/10/2003EP1369427A2 HIV-3 retrovirus strains and their use
12/10/2003EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use
12/10/2003EP1368656A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
12/10/2003EP1368644A2 ANTIBODIES SPECIFIC FOR UNGULATE PrP
12/10/2003EP1368476A2 Rearranged squamous cell carcinoma antigen genes ii
12/10/2003EP1368474A1 Polynucleotide useful for modulating cancer cell proliferation
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/10/2003EP1368466A2 Transgenic cell and animal modeling ige-mediated human allergic responses and use thereof
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368456A2 Anti-bacterial vaccine compositions
12/10/2003EP1368380A2 Stabilization of antibodies or fragments thereof
12/10/2003EP1368379A2 Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368376A2 Pro-apoptotic proteins and dna molecules encoding them
12/10/2003EP1368373A2 Environmentally regulated genes, involved in the virulence of streptococcus suis
12/10/2003EP1368060A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
12/10/2003EP1368052A2 Agents, which inhibit apoptosis in cells that are involved in wound healing
12/10/2003EP1368051A2 Urocortin-iii and uses thereof
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0912611B1 Human monoclonal antibodies to the hepatitis b surface antigen
12/10/2003EP0754059B1 Methods and compositions useful for inhibition of angiogenesis
12/10/2003EP0724456B1 Antibodies to cd40
12/10/2003EP0680316B1 Novel parasitic helminth proteins
12/10/2003EP0671920B1 An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1461344A Multivalent target binding protein
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1460686A Method for preparing alpha-fetoglobulin transspecific factor
12/10/2003CN1460522A Egg yolk antibody composite for preventing and curing diseases and its preparaion method
12/10/2003CN1130227C Viral agent associated with mystery swine disease
12/09/2003US6660905 Mice comprising engrafted functional human hepatocytes
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/09/2003US6660842 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660834 Reagents useful for detecting diseases of the gastrointestinal tract
12/09/2003US6660520 Nrde
12/09/2003US6660512 Human lysozyme gene, it's encoded polypeptide and the method of preparing them
12/09/2003US6660501 Production of proteins by cell culture
12/09/2003US6660499 Nucleic acid encoding human DCR5, a protein related to DAN (Differential-screening-selected gene Aberrative in Neuroblastoma)
12/09/2003US6660497 Pectinophora gossypiella (pink bollworm) Bacillus thuringiensis toxin receptor BT-R2
12/09/2003US6660488 Antibodies for the alpha platelet-derived growth factor receptor
12/09/2003US6660482 Diagnosing sepsis by contacting a bodily fluid with a ligand which binds to an inter-alpha trypsin inhibitor (ITI) polypeptide to form an ITI-ligand complex and detecting the complex.
12/09/2003US6660481 Sandwich assays for collagen type I fragments
12/09/2003US6660275 Amplification nucleic acids
12/09/2003US6660274 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
12/09/2003US6660269 Canine tropical pancytopenia;
12/09/2003US6660267 Prevention and treatment of sepsis
12/09/2003US6660266 Ligating agent comprises (i) at least two IgG Fc regions or (ii) a multivalent antibody which binds to Fe gamma I receptor.
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/07/2003CA2389897A1 Process for selectively isolating igy antibodies from egg yolk of an anseriform bird and igy antibodies obtained thereby
12/04/2003WO2003100429A2 Diagnosis of hepatocellular carcinoma
12/04/2003WO2003100428A2 Method for diagnosing a tumor in a patient by determining pibf
12/04/2003WO2003100419A1 Methods for using the cd163 pathway for modulating an immune response
12/04/2003WO2003100080A2 Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100029A2 Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use
12/04/2003WO2003100008A2 Neutralizing human anti-igfr antibody
12/04/2003WO2003100006A2 Method of improved prostate cancer detection
12/04/2003WO2003100005A2 Universal chimera bank
12/04/2003WO2003099999A2 Generation and selection of protein library in silico
12/04/2003WO2003099996A2 Detection of secreted polypeptides
12/04/2003WO2003099995A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/04/2003WO2003099957A1 Rnp immunoprecipitation assay
12/04/2003WO2003099869A1 Antibody capable of recognizing 8-nitroguanine
12/04/2003WO2003099868A2 Method for obtaining anti-idiotype antibodies
12/04/2003WO2003099861A1 Use of a pestivirus ns3-like protein for inducing cell apoptosis
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099779A2 Hemipteran muscarinic receptor
12/04/2003WO2003099330A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003WO2003099329A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003WO2003099328A1 Methods and materials for treating inflammatory conditions
12/04/2003WO2003099312A1 Method for determining immune system affecting compounds
12/04/2003WO2003099226A2 Antibody peg positional isomers, compositions comprising same, and use thereof
12/04/2003WO2003099205A2 Treatment of renal carcinoma using antibodies against the egfr
12/04/2003WO2003099196A2 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
12/04/2003WO2003099193A2 Vaccines
12/04/2003WO2003099104A2 Elisa assay of serum soluble cd22 to assess tumor burden/relapse in subjects with leukemia and lymphoma
1 ... 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 ... 1494